GGrantIndex
← Leaderboards

Jeffrey None Crawford

Duke University

$10,066,024
Attributed
$14,337,543
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,337,543 · 8

By mechanism

T32$4,751,963 · 1
U10$4,251,731 · 2
UG1$3,094,644 · 1
P30$2,239,205 · 3
M01$0 · 1

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Trials

Research focus

Clinical TrialsClinical ResearchMalignant NeoplasmsGrantOncologySiteMemberProgramsResourcesResearch PersonnelEnrollmentBasePrincipal InvestigatorFacultyOrganizational StructureLeadModalityData ManagementPhysiciansCommunitiesPatient ParticipationConduct Clinical TrialsBiologyCancer Therapy

Grant awards (54)

NCI National Clinical Trials Network (UG1)$406,019
UG1 · FY2025 · CA
NCI National Clinical Trials Network (UG1)$410,792
UG1 · FY2024 · CA
NCI National Clinical Trials Network (UG1)$439,350
UG1 · FY2023 · CA · contact PI
NCI National Clinical Trials Network (UG1)$447,677
UG1 · FY2022 · CA · contact PI
NCI National Clinical Trials Network (UG1)$455,656
UG1 · FY2021 · CA · contact PI
NCI National Clinical Trials Network (UG1)$463,561
UG1 · FY2020 · CA · contact PI
NCI National Clinical Trials Network (UG1)$471,589
UG1 · FY2019 · CA · contact PI
NCI National Clinical Trials Network U10$413,627
U10 · FY2018 · CA · contact PI
NCI National Clinical Trials Network U10$392,946
U10 · FY2017 · CA · contact PI
NCI National Clinical Trials Network U10$392,946
U10 · FY2016 · CA · contact PI
NCI National Clinical Trials Network U10$411,893
U10 · FY2015 · CA · contact PI
NCI National Clinical Trials Network U10$408,100
U10 · FY2014 · CA · contact PI
Cancer and Leukemia Group B$85,701
U10 · FY2013 · CA · contact PI
Research Training in Cancer Biology and Therapy$568,113
T32 · FY2012 · CA · contact PI
Cancer and Leukemia Group B$99,190
U10 · FY2012 · CA · contact PI
Research Training in Cancer Biology and Therapy$544,388
T32 · FY2011 · CA · contact PI
Cancer and Leukemia Group B$95,798
U10 · FY2011 · CA · contact PI
Research Training in Cancer Biology and Therapy$527,095
T32 · FY2010 · CA · contact PI
Cancer and Leukemia Group B$104,247
U10 · FY2010 · CA · contact PI
Research Training in Cancer Biology and Therapy$553,455
T32 · FY2009 · CA · contact PI
CLINICAL TRIALS SHARED RESOURCES$348,380
P30 · FY2009 · CA · contact PI
Cancer and Leukemia Group B$157,170
U10 · FY2009 · CA · contact PI
CANCER PROTOCOL COMMITTEE$63,537
P30 · FY2009 · CA · contact PI
Research Training in Cancer Biology and Therapy$511,416
T32 · FY2008 · CA · contact PI
CLINICAL TRIALS SHARED RESOURCES$238,000
P30 · FY2008 · CA · contact PI
Cancer and Leukemia Group B$166,705
U10 · FY2008 · CA · contact PI
CANCER PROTOCOL COMMITTEE$43,426
P30 · FY2008 · CA · contact PI
Research Training in Cancer Biology and Therapy$525,154
T32 · FY2007 · CA · contact PI
CLINICAL TRIALS SHARED RESOURCES$231,072
P30 · FY2007 · CA · contact PI
Cancer and Leukemia Group B$160,142
U10 · FY2007 · CA · contact PI
CANCER PROTOCOL COMMITTEE$42,163
P30 · FY2007 · CA · contact PI
Research Training in Cancer Biology and Therapy$492,472
T32 · FY2006 · CA · contact PI
CLINICAL TRIALS SHARED RESOURCES$224,342
P30 · FY2006 · CA · contact PI
Cancer and Leukemia Group B$152,954
U10 · FY2006 · CA · contact PI
CANCER PROTOCOL COMMITTEE$40,935
P30 · FY2006 · CA · contact PI
Research Training in Cancer Biology and Therapy$523,950
T32 · FY2005 · CA
CLINICAL TRIALS SHARED RESOURCES$217,807
P30 · FY2005 · CA
Cancer and Leukemia Group B$164,790
U10 · FY2005 · CA
CANCER PROTOCOL COMMITTEE$39,743
P30 · FY2005 · CA
Research Training in Cancer Biology and Therapy$505,920
T32 · FY2004 · CA
Cancer and Leukemia Group B$222,743
U10 · FY2004 · CA
Cancer and Leukemia Group B$241,732
U10 · FY2003 · CA
CANCER AND LEUKEMIA GROUP B$218,694
U10 · FY2002 · CA
Core--Protocol specific research$187,450
P30 · FY2002 · CA
CANCER AND LEUKEMIA GROUP B$198,198
U10 · FY2001 · CA
Core--Protocol specific research$187,450
P30 · FY2001 · CA
Core--Protocol specific research$187,450
P30 · FY2001 · CA
Core--Protocol specific research$187,450
P30 · FY2001 · CA
Core--Protocol specific research$0
P30 · FY2001 · CA
CANCER AND LEUKEMIA GROUP B$164,155
U10 · FY2000 · CA
Core--Protocol specific research$0
P30 · FY2000 · CA
Pharmacokinetics of non-small lung cell cancer receiving gemcitabine &cisplatin$0
M01 · FY2000 · RR
Core--Protocol specific research$0
P30 · FY2000 · CA
Pharmacokinetics of non-small lung cell cancer receiving gemcitabine &cisplatin$0
M01 · FY2000 · RR